Protagonist Therapeutics (PTGX)
Nasdaq • PTGX • US74366E1029
ORTEX Data Highlights
ORTEX Data Highlights
As of Oct 27, 2026, ORTEX estimated 19.3% of free float sold short, 12.8 days to cover, cost to borrow 0.47%. Sign up for live short interest data.
Market Cap
8.8b USD | # 1758 in US
Volume
657.29k shares | 94.29m USD
Shares Outstanding
65.27m
Free Float Shares
81.89% | 53.45m
